Back
Elite Pharmaceuticals 10K Form
Buy
58
ELTP
Elite Pharmaceuticals
Last Price:
$0.56
Seasonality Move:
60.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-16 | 10Q | ELTP/Elite Pharmaceuticals Quarterly |
| 2020-11-16 | 10Q | ELTP/Elite Pharmaceuticals Quarterly |
| 2020-08-14 | 10Q | ELTP/Elite Pharmaceuticals Quarterly |
| 2020-06-29 | 10K | ELTP/Elite Pharmaceuticals Annual |
| 2020-02-10 | 10Q | ELTP/Elite Pharmaceuticals Quarterly |
| 2019-11-12 | 10Q | ELTP/Elite Pharmaceuticals Quarterly |
Receive ELTP News And Ratings
See the #1 stock for the next 7 days that we like better than ELTP
ELTP Financial Statistics
Sales & Book Value
| Annual Sales: | $56.6M |
|---|---|
| Cash Flow: | $1.4M |
| Price / Cash Flow: | 349.26 |
| Annual Sales: | $0.04 |
| Price / Book: | 12.66 |
Profitability
| EPS (TTM): | -0.00870 |
|---|---|
| Net Income (TTM): | $-6.4M |
| Gross Margin: | $26.4M |
| Return on Equity: | -12.55% |
| Return on Assets: | -7.89% |
Elite Pharmaceuticals Earnings Forecast
Key Elite Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 18 years for ELTP is 46.55%.
-
The Selling, General & Administrative Expenses for ELTP have been equal to 12.90% of Gross Profit Margin.
-
The Research & Development expenses have been 12.16% of Revenue.
-
The Interest Expense is 2.93% of Operating Income.
-
The Net Earning history of ELTP is 35.51% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 12 years.
Elite Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ELTP |
| Website: | elitepharma.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 3.52 |
| Quick Ratio: | 2.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 28 |
|---|---|
| Forward P/E Ratio: | 0 |
ELTP Technical Analysis vs Fundamental Analysis
Buy
58
Elite Pharmaceuticals (ELTP)
is a Buy
Is Elite Pharmaceuticals a Buy or a Sell?
-
Elite Pharmaceuticals stock is rated a BuyThe current Elite Pharmaceuticals [ELTP] share price is $0.56. The Score for ELTP is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.